Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greeve

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Genetics|July 6, 2005
Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European rootsC Solcà, Z Stanga, B Pandit, et al.
Journal of Lipid Research|September 1, 1996
Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbitsJ Greeve, V K Jona, N R Chowdhury, et al.
Praxis|September 30, 2005
[61-year-old patient with long-term diarrhea and reactive depressive mood disorder]S Blaser, C Luder, R Weimann, et al.
Oncogene|December 22, 1999
Absence of APOBEC-1 mediated mRNA editing in human carcinomasJ Greeve, H Lellek, F Apostel, et al.
The Journal of Pathology|March 2, 2006
Immunoglobulin class-switch recombination occurs in mantle cell lymphomasW Klapper, M Szczepanowski, K Heidorn, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Endocytic mechanisms for uptake and metabolism of chylomicron remnants in the liverE Windler, J Greeve, S Jäckle, et al.
Journal of Hepatology|August 22, 2000
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic miceA R Mensenkamp, M J van Luyn, H van Goor, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)A Kurreck, M Geissler, U M Martens, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Genetics|July 6, 2005
Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European rootsC Solcà, Z Stanga, B Pandit, et al.
Journal of Lipid Research|September 1, 1996
Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbitsJ Greeve, V K Jona, N R Chowdhury, et al.
Praxis|September 30, 2005
[61-year-old patient with long-term diarrhea and reactive depressive mood disorder]S Blaser, C Luder, R Weimann, et al.
Oncogene|December 22, 1999
Absence of APOBEC-1 mediated mRNA editing in human carcinomasJ Greeve, H Lellek, F Apostel, et al.
The Journal of Pathology|March 2, 2006
Immunoglobulin class-switch recombination occurs in mantle cell lymphomasW Klapper, M Szczepanowski, K Heidorn, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Endocytic mechanisms for uptake and metabolism of chylomicron remnants in the liverE Windler, J Greeve, S Jäckle, et al.
Journal of Hepatology|August 22, 2000
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic miceA R Mensenkamp, M J van Luyn, H van Goor, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)A Kurreck, M Geissler, U M Martens, et al.
Pageof 3